Key facts
- Notable investors include General Inception.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Trench Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Trench Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Trench Therapeutics
Operator of a biotech research platform intended to provide biotherapeutic products. The company researches the nasal microbiome to discover antibiotic products, providing medical companies with the prevention and treatment of infectious and inflammatory diseases.
- Sector
- Healthcare
- HQ
- Portola Valley, CA, United States
- Founded
- 2023
- Website
- trenchtx.com/
- Ownership
- Privately Held (backing)
Trench Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Trench Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Trench Therapeutics in its N-PORT filings yet. We sweep new filings monthly.